NCT01630135 Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis Status COMPLETED Phase PHASE3
NCT01627587 A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole Status COMPLETED Phase PHASE1
NCT01627561 Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old Status COMPLETED Phase PHASE3
NCT01627340 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01627327 Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT01627223 Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation Status TERMINATED Phase PHASE4
NCT01626820 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults Status COMPLETED Phase PHASE3
NCT01626352 Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy Status COMPLETED Phase PHASE2
NCT01622790 Evaluation of the Bioequivalence of a Combined Formulated Tablet Status COMPLETED Phase PHASE1
NCT01622660 Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy Status TERMINATED Phase PHASE2
NCT01622231 Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis Status COMPLETED Phase PHASE3
NCT01621802 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Status COMPLETED Phase PHASE3
NCT01621204 A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients Status COMPLETED Phase PHASE3
NCT01619774 An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor Status COMPLETED Phase PHASE2
NCT01616472 WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) Status COMPLETED Phase N/A
NCT01616459 Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants Status COMPLETED Phase PHASE2
NCT01615796 Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses Status COMPLETED Phase PHASE1
NCT01615783 Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population Status COMPLETED Phase N/A